Silibinin, as a dual potential inhibitor of acetylcholinesterase and Aβ peptide aggregation for AD therapy, was evaluated on APPswe/PS1dE9 double Tg mice model by Duan et al. [66]. The gene discussed is ACHE; the disease is Alzheimer disease.